Medesthetics

SEP-OCT 2013

MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.

Issue link: https://medesthetics.epubxp.com/i/156138

Contents of this Issue

Navigation

Page 15 of 80

Confidence comes from experience Proven to last up to 4 months in 25% of patients (102/403) vs 2% (2/128) for placebo per physician assessment1 ● Dosing and injection techniques you know well ● #1 prescribed product of its kind in the world2,* *Data collected through March 2013. Indication BOTOX® Cosmetic (onabotulinumtoxinA) for injection is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients ≤ 65 years of age. Please see Important Safety Information, including Boxed Warning, on adjacent page.

Articles in this issue

Archives of this issue

view archives of Medesthetics - SEP-OCT 2013